c 1311 has been researched along with paclitaxel in 3 studies
Studies (c 1311) | Trials (c 1311) | Recent Studies (post-2010) (c 1311) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
52 | 1 | 23 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Comijn, E; De Marco, C; Peters, GJ; Tesei, A; Zaffaroni, N; Zoli, W | 1 |
Alami, N; Belanger, S; Grieshaber, CK; Juste, S; Leyland-Jones, B; Paterson, J | 1 |
Baras, AS; Bekiranov, S; Burke, DJ; Havaleshko, DM; Lee, J; Moon, K; Smith, SC; Theodorescu, D | 1 |
3 other study(ies) available for c 1311 and paclitaxel
Article | Year |
---|---|
Comparative evaluation of C1311 cytotoxic activity and interference with cell cycle progression in a panel of human solid tumour and leukaemia cell lines.
Topics: Aminoacridines; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; CDC2 Protein Kinase; Cell Division; Cell Proliferation; Cyclin B; Cyclin B1; Doxorubicin; Drug Therapy, Combination; G2 Phase; Humans; Immunoblotting; Immunoprecipitation; Neoplasms; Paclitaxel; Rhodamines; Tumor Cells, Cultured | 2007 |
Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay.
Topics: Aminoacridines; Animals; Antineoplastic Agents; Camptothecin; Capecitabine; Cell Line, Tumor; Cell Proliferation; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Fluorouracil; HT29 Cells; Humans; In Vitro Techniques; Irinotecan; Mice; Mice, Nude; Organoplatinum Compounds; Oxaliplatin; Paclitaxel | 2007 |
Use of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agents.
Topics: Algorithms; Aminoacridines; Antineoplastic Agents; Biomarkers, Pharmacological; Computer Simulation; Drug Interactions; Drug Screening Assays, Antitumor; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Models, Genetic; Paclitaxel; Saccharomyces cerevisiae; Statistics, Nonparametric; Transcription, Genetic; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2011 |